Clinical study to assess the effect of QVA149 on cardiac functions in COPD patients

Update Il y a 4 ans
Reference: EUCTR2014-004680-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the effect of once-daily QVA149 (110/50 µg o.d.) compared with placebo on left ventricular enddiastolic volume as measured by MRI after 2 weeks of treatment in hyperinflated COPD patients.


Inclusion criteria

  • Chronic Obstructive Pulmonary Disease (COPD)

Links